| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Proteoglycan biosynthesis 0.911065852002712 3.906910235764211 9.348386271335052e-05 0.054637122454418 0.0013703366217249 2 Q8NCH0 1 |
| Congenital generalized lipodystrophy cgl 0.8665987780040683 3.691174139454915 0.0002232212415005 0.1255594264451177 0.0025312446441853 2 P31751 1 |
| Zinc homeostasis 0.8628649015614323 3.672790522798941 0.0002399161478598 0.1342913893393702 0.0026501303854154 2 Q8TAD4 1 |
| Metabolism of spingolipids in er and golgi apparatus 0.8540393754242988 3.629168501209608 0.0002843356061201 0.1571025677646168 0.0028149327948397 2 O95470 1 |
| Eicosanoid synthesis 0.8048200950441151 3.3813829381954643 0.0007212195571641 0.3518345793484552 0.005966607289435 2 P09960 1 |
| Vitamin a and carotenoid metabolism 0.918756645377494 2.8272759742741664 0.0046945850369148 0.9408742747586522 0.0276612314429985 5 P09455,Q8WTV0,O94788 3 |
| Statin inhibition of cholesterol production 0.9089364593951732 2.7851914522531587 0.0053496126352348 0.9601944051956928 0.0299169144817615 5 P35610,Q8WTV0,P04035,P37268 4 |
| Monoamine transport 0.682620502376099 2.7302314434272663 0.0063289875621173 0.97798011582385 0.0342677614849774 2 O15127 1 |
| Ptf1a related regulatory pathway 0.7348374128435577 2.568778127355793 0.0102057777697044 0.9978986735457728 0.0519443487098114 3 Q06330 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5900701500812829 2.5267651618438443 0.011511845017176 0.9990497164811312 0.0567099906174001 24 Q15392,P04035,O75845,Q14534,P35610,Q15800,Q16850,Q14739,O95864,P37268 10 |
| 15q112 copy number variation syndrome 0.7164685908319147 2.474898134873805 0.0133274182330065 0.9996852186272644 0.0645949867583623 3 Q9BSJ2,Q06787 2 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.7111221178355682 2.447370619030438 0.0143902780103077 0.999835300532525 0.0680988746787006 3 P31751 1 |
| Kennedy pathway from sphingolipids 0.70411592180622 2.4111586722404352 0.0159019285672135 0.9999345263118982 0.0730051851718566 3 O95470 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.645030264366985 2.3684749150074405 0.0178615915851438 0.9999802398665332 0.0813243677475111 15 P50402,P11802,P55209,P25054,P48729,Q13547,O75844,O60725 8 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8254623117442353 2.2402464698543483 0.0250749263343548 0.9999997646494504 0.0996513210066798 6 Q15392,Q14739,Q16850 3 |
| Sarscov2 and covid19 pathway 0.6658698267051009 2.2106886524514273 0.0270574048740106 0.999999930750368 0.1029862279563711 3 Q8WTV0 1 |
| Mitochondrial complex i assembly model oxphos system 0.530931718098215 2.159219657897223 0.0308331296803763 0.99999999330833 0.1136853431773384 26 O96000,Q9P0J0,P03886,Q96CU9,O43676,Q7L592,Q9Y6M9 7 |
| Ketogenesis and ketolysis 0.7553299455230367 2.097503894592411 0.0359489927745872 0.9999999997219596 0.1278422760800412 5 O43772,P35610,P53985 3 |
| Striated muscle contraction pathway 0.7457779526170878 2.0528842615921943 0.040083803765111 0.9999999999789996 0.1400602678071611 5 P08670,P09493 2 |
| Sphingolipid metabolism overview 0.7592759260141979 2.0404074666559526 0.0413097588454143 0.9999999999902576 0.1426848567016897 7 Q96G23,O95470 2 |
| Sphingolipid metabolism integrated pathway 0.7592759260141979 2.0404074666559526 0.0413097588454143 0.9999999999902576 0.1426848567016897 7 Q96G23,O95470 2 |
| Relationship between inflammation cox2 and egfr 0.7055997892443272 2.036554616030879 0.0416946946952012 0.9999999999923468 0.143191494353234 4 P31751 1 |
| Histone modifications 0.735839140684961 2.006229990699803 0.0448317154957174 0.9999999999989334 0.1505243632007048 5 Q01105,Q03164 2 |
| Mecp2 and associated rett syndrome 0.5501956313033542 2.0021600021142425 0.0452675259503043 0.9999999999991892 0.1511432394229606 19 P35637,P67809,Q00013,P52597,Q13547,P31943 6 |
| Allograft rejection 0.6757963879912265 1.972955551597054 0.0485006266435878 0.9999999999998944 0.1584178076782409 10 P08183,P08670,P01889,Q9BY49,P04439 5 |
| Nonalcoholic fatty liver disease 0.4204761947676654 1.956238571630907 0.0504370567071985 0.999999999999969 0.1623753312440552 49 P14406,P31751,O96000,Q9P0J0,P00403,Q9UDW1,O14949,O43676,Q9Y6M9 9 |
| Influence of laminopathies on wnt signaling 0.6972131817692068 1.9549489776260267 0.0505890928174845 0.9999999999999718 0.1623753312440552 9 O75844,O60725 2 |
| Il10 antiinflammatory signaling pathway 0.7195198377475529 1.929127316068849 0.0537150586228551 0.999999999999996 0.1690196347242721 5 P09601 1 |
| Oxidation by cytochrome p450 0.7156040616851254 1.9105359633836343 0.0560642404906615 0.9999999999999992 0.1745834639113345 5 Q16850,O43169 2 |
| Familial partial lipodystrophy fpld 0.729780794558107 1.9018947547709928 0.0571849150649705 0.9999999999999996 0.1771553296600377 7 O75844,O60725 2 |
| Endothelin pathways 0.7245905172051255 1.8773204569888928 0.0604741860856357 1.0 0.1854336012115666 7 P42892 1 |
| Proteasome degradation 0.4372829687170474 1.8528132452796464 0.0639091311019073 1.0 0.1910914815534642 42 P49721,Q99436,P20618,P60900,P28072,P01889,P46934,P28070,P25787,O43242,P04439 11 |
| Neuroinflammation 0.6648080867349921 1.8347993416679544 0.0665354262132975 1.0 0.1960185840891756 4 P00403 1 |
| Resistin as a regulator of inflammation 0.7330824912040439 1.8243631127985247 0.068097194761967 1.0 0.1986719128735058 6 P31751,P19174 2 |
| Ethanol effects on histone modifications 0.6436522355960118 1.8012476813153309 0.0716638500609654 1.0 0.208067506698745 10 P00374,Q13547,Q96KQ7,O94788 4 |
| Hedgehog signaling pathway wp4249 0.5899428914987208 1.7988767341073546 0.0720381816537583 1.0 0.20811848963205 3 P48729 1 |
| Nanomaterial induced apoptosis 0.7270872643514998 1.7967583954403348 0.0723739839153052 1.0 0.20811848963205 6 O95831,Q9NR28 2 |
| Type ii diabetes mellitus 0.6378463975155961 1.6992368240124875 0.0892745706605464 1.0 0.2449955112647872 4 O14920 1 |
| Adipogenesis 0.5653794131419114 1.637774809643976 0.1014686782538278 1.0 0.26983484792279 13 P43490,O00767,P14174,O75844,P16220 5 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.6466263503105519 1.5776560688490784 0.1146446439109016 1.0 0.3021992587300522 5 P19174,P16220 2 |
| Angiogenesis 0.6114333182872901 1.5648873550148306 0.1176093241360807 1.0 0.3073182774164544 4 Q05397,P19174 2 |
| Electron transport chain oxphos system in mitochondria 0.3759545315920809 1.559526485359927 0.1188718209423851 1.0 0.3092725731011838 52 P14406,O96000,P12236,P00403,P03886,Q9UDW1,O75964,Q9Y6M9,P06576,O14949,O43676,P00846 12 |
| 1q211 copy number variation syndrome 0.6192941845517633 1.5518809265153866 0.1206907175035496 1.0 0.3126513845673851 9 Q9NPH0 1 |
| Leptininsulin signaling overlap 0.4837067209775839 1.547183975790538 0.1218188888482403 1.0 0.3142195373295813 2 O14654 1 |
| Omega3 omega6 fatty acid synthesis 0.6292999638474515 1.4926104172591972 0.1355391949000788 1.0 0.3380043823026862 5 O95864 1 |
| Cholesterol biosynthesis pathway 0.523152795958212 1.4798538318236023 0.1389122588761977 1.0 0.3449845767958465 14 P04035,O75845,Q15800,Q16850,P37268 5 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.5418833404793947 1.4009655163496797 0.1612243852031614 1.0 0.3908172876902694 12 Q32P28,Q96AY3,O75718,P13674,P07237,O15460 6 |
| Modulators of tcr signaling and t cell activation 0.5674417349543365 1.3841574428450554 0.1663102511151937 1.0 0.3972028677747697 10 P19174,O96000,P62993 3 |
| S1p receptor signal transduction 0.6071804202580658 1.3833824623805553 0.1665476250902529 1.0 0.3972028677747697 5 P31751 1 |
| Translation factors 0.4008115859410626 1.3609169531269445 0.1735399353558306 1.0 0.4106200832632056 37 Q15056,P55010,O75822,O15372,O75153,Q9NR50,P60228,Q9H074,Q9UI10,P23588 10 |
| Progeriaassociated lipodystrophy 0.581275098214099 1.3507681009868722 0.1767697294116526 1.0 0.4166219897113851 9 O60725 1 |
| Alzheimers disease and mirna effects 0.3220445452760919 1.344369246408455 0.1788290134670134 1.0 0.417899360849537 86 Q9Y277,P16615,P20618,O43242,P04350,Q92542,P0DP25,O14920,P60900,Q9NSK0,P31751,O14641,P45880,P28072,Q9NQC3,P25054,Q96IX5,P28070,P25787,P49721,P28074,Q9H0B6,O95197,P12236,P21796,P48729,Q99436 27 |
| Egfr tyrosine kinase inhibitor resistance 0.4855903814636628 1.3426117336601906 0.1793977289503836 1.0 0.417899360849537 15 P31751,P19174 2 |
| Alzheimers disease 0.320920101042432 1.332564340197397 0.1826748140309384 1.0 0.4196885279735324 84 Q9Y277,P16615,P20618,O43242,P04350,Q92542,O14920,P60900,Q9NSK0,P31751,O14641,P45880,P28072,Q9NQC3,P25054,P28070,P25787,P49721,Q9H0B6,O95197,P12236,P21796,Q99436 23 |
| Mitochondrial complex iii assembly 0.5287495247126472 1.322894941700497 0.1858703177183183 1.0 0.4247454788924308 12 P22695,Q6DKK2,Q9UDW1,O14949 4 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.5435425464720676 1.2143015786943856 0.2246325830282267 1.0 0.4747934541955089 4 P09601 1 |
| Cellular proteostasis 0.5432811754574136 1.2129429371302225 0.2251516380128453 1.0 0.4747934541955089 4 Q9UHV9 1 |
| Cardiac progenitor differentiation 0.4266802443991839 1.1834327355099588 0.2366376900096194 1.0 0.4882395146727038 2 Q16539 1 |
| T cell receptor and costimulatory signaling 0.5369320790916193 1.1799328629488397 0.2380269181349454 1.0 0.4882395146727038 4 P19174 1 |
| Ferroptosis 0.4142805493711782 1.174463659562908 0.2402093596858607 1.0 0.4907256137229524 24 P09601,P04035,P45880,Q9UKU0,Q15043,Q96QD8,P37268 7 |
| Sphingolipid metabolism in senescence 0.5257267506028872 1.1519537561827518 0.249340076598391 1.0 0.4988369975522901 10 Q96G23,P11802,P04062 3 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.4757215619694478 1.1510756639693407 0.2497011088192662 1.0 0.4988369975522901 3 P27361,P40763 2 |
| Neovascularisation processes 0.4757215619694471 1.1510756639693358 0.2497011088192682 1.0 0.4988369975522901 3 Q04864,P27361 2 |
| Sphingolipid pathway 0.5577814046473619 1.1395033580773184 0.2544932684638123 1.0 0.5031264945616817 8 Q96G23 1 |
| Folate metabolism 0.4767532836866315 1.0923333965377404 0.2746865862714727 1.0 0.5308252036950325 13 P00374 1 |
| Riboflavin and coq disorders 0.5463869166096027 1.08103447351296 0.2796817792007253 1.0 0.5336812571174615 5 Q16134,Q8NI60 2 |
| Mapk pathway in congenital thyroid cancer 0.4052953156822685 1.0462513481150035 0.2954450013113996 1.0 0.5497289343286414 2 P27361 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.5388251297589225 1.0434161920927003 0.2967555774545676 1.0 0.550463277932701 5 O14641,P25054 2 |
| Pdgfrbeta pathway 0.5519028496669229 1.0344448625684206 0.3009282406056224 1.0 0.5564857618583972 7 P19174 1 |
| Vitamin d metabolism 0.4005431093007406 1.0158240146875677 0.3097131980790031 1.0 0.5663956266554732 2 P04062 1 |
| Mitochondrial complex iv assembly 0.4642706764562437 1.015102771705546 0.3100568405485036 1.0 0.5663956266554732 13 P14406,P20674,Q7KZN9,Q9Y2R0,P00403 5 |
| Serotonin receptor 467 and nr3c signaling 0.527253946233439 0.985952400688098 0.3241564711587661 1.0 0.586801322790417 5 P49137 1 |
| Nonsmall cell lung cancer 0.4410607793038735 0.952672094096996 0.340756236665733 1.0 0.6076988078222718 14 P31751,P19174,P62993 3 |
| Calcium regulation in cardiac cells 0.393637988620105 0.9449585646984672 0.3446800304472188 1.0 0.612877805617688 22 P0DP25,P16615,Q13555,P08754,Q14012,P05026,Q9Y3B8 7 |
| Vitamin d receptor pathway 0.4639937826096085 0.936852450031902 0.3488344612184602 1.0 0.6150857333275696 12 P08183,Q92783 2 |
| Apoptosis modulation and signaling 0.4056541596894343 0.936546133026242 0.3489920716550769 1.0 0.6150857333275696 18 O43464,O95831,Q9NR28 3 |
| Camkk2 pathway 0.4528021200538841 0.8706618896264935 0.3839387930510121 1.0 0.6555318597263018 12 Q14012,P09601 2 |
| Cannabinoid receptor signaling 0.4758831521739223 0.8638030286154732 0.3876961038441049 1.0 0.6569190075069252 4 Q16539,P27361,P10644 3 |
| Notch signaling 0.5023992989248546 0.8565075417034931 0.3917171030840971 1.0 0.6612976936897257 8 Q13547,Q06330 2 |
| Bdnftrkb signaling 0.5015492170190453 0.852207598608997 0.3940988799685359 1.0 0.6621436149890222 8 P19174,P16220,P62993 3 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.473505434782617 0.8516260901175662 0.3944216541864724 1.0 0.6621436149890222 4 P06753,P61201,P18031 3 |
| Mitochondrial immune response to sarscov2 0.4993641595608861 0.8411648124513603 0.4002556101496299 1.0 0.6663535227144809 8 Q9Y6M9 1 |
| Tlr4 signaling and tolerance 0.4690575009677518 0.828895545537581 0.4071635161951057 1.0 0.6741192100089767 4 Q15629 1 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.492435642041518 0.8144737775550664 0.4153735884263589 1.0 0.6802166938535197 5 P04035 1 |
| Neural crest differentiation 0.479012825350697 0.8073024912258967 0.4194922290909759 1.0 0.6827061764702516 9 Q13547,Q06330 2 |
| Circadian rhythm genes 0.3324519476722367 0.776629677591267 0.4373772869338672 1.0 0.6910250455594399 41 P43490,Q15233,Q8WXF1,P11802,Q03164,P54802,Q9BWF3,Q13547,Q14103,P23246 10 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.4469275186464018 0.7727353154202121 0.4396790418052412 1.0 0.6910250455594399 11 P31751,Q13547 2 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.5068950306934578 0.7567668119645259 0.4491895792616507 1.0 0.7030284821256565 6 Q8IXH7 1 |
| Reninangiotensinaldosterone system raas 0.4780762865718766 0.7447921334847848 0.4563973911743302 1.0 0.7087893706167891 5 Q13555,Q14012,P0DP25 3 |
| Estrogen signaling pathway 0.478072490309432 0.7447738212253701 0.4564084632757028 1.0 0.7087893706167891 5 P16220,O14920 2 |
| Exrna mechanism of action and biogenesis 0.4030560271646911 0.7377097647255452 0.460690837042528 1.0 0.7117614217546513 3 Q9HAV4,Q9UPY3 2 |
| Energy metabolism 0.4396325420865865 0.7318617918586556 0.4642529290131469 1.0 0.7138221953491118 11 Q13555,Q99873,Q13547 3 |
| Phosphodiesterases in neuronal function 0.4019593244501118 0.7316206667985673 0.4644001304184737 1.0 0.7138221953491118 3 O43924 1 |
| Mitochondrial complex ii assembly 0.3540393754243044 0.722203636381523 0.4701692879603927 1.0 0.7188970106247344 2 P21912 1 |
| Egfegfr signaling pathway 0.3279304885810513 0.6825187142146555 0.4949110134375369 1.0 0.7359076949877087 38 O95630,Q9P0J0,P00403,Q92783,P46934 5 |
| Hippoyap signaling pathway 0.3915110356536567 0.6740114950695353 0.5003040055685224 1.0 0.7359076949877087 3 P27348,Q13043 2 |
| Glioblastoma signaling pathways 0.3835768285890463 0.6648498189052529 0.5061465545109147 1.0 0.7401315797106077 15 P31751,P19174,P62993 3 |
| Ebola virus infection in host 0.3248652414150175 0.6407453634742044 0.5216881359152334 1.0 0.7536888694352291 37 Q07021,O15118,O75569,P01889,P46934,P04439,Q9H270 7 |
| Complement system in neuronal development and plasticity 0.4204456099403153 0.6259406120749715 0.5313538952767147 1.0 0.7619890318514029 11 Q5KU26,Q9NR28 2 |
| Neural crest cell migration in cancer 0.4408557545944103 0.6113434910991481 0.5409722044620109 1.0 0.7686153543301857 9 P31751 1 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.3958441859955546 0.6011754524909668 0.5477231324840492 1.0 0.7763717042993244 13 P55010,O15372,O75822 3 |
| Notch signaling pathway 0.4132817829092088 0.587113172689315 0.5571277012081244 1.0 0.7841539775786481 11 Q06330 1 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.4334911825969103 0.5745959083949422 0.5655646198987869 1.0 0.790237370408794 9 P19174,P16220 2 |
| Myometrial relaxation and contraction pathways 0.3530315249343052 0.5675487432096974 0.5703414199971828 1.0 0.7934610958757103 18 P0DP25,P19174,P16615,P10644,Q13555,P16220,Q9Y3B8 7 |
| Tryptophan metabolism 0.366846507878424 0.5588913521307624 0.5762358717058869 1.0 0.7979671863945575 15 Q15392,O94788 2 |
| Mevalonate pathway 0.4558294717872856 0.5264852887162497 0.5985510707799946 1.0 0.8215423713290725 6 Q9BWD1,P04035 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3223194003838702 0.5262305201453509 0.5987280509852475 1.0 0.8215423713290725 29 Q8WTV0,P04035,Q14534,Q16850,P37268 5 |
| Hepatitis b infection 0.3325836310281651 0.5095239828673276 0.6103849921374651 1.0 0.8318398645682914 23 Q9Y277,P31751,Q16531,P62993,O14920,Q15904,O00571 7 |
| Nephrotic syndrome 0.3784751738291313 0.5016654948786566 0.6159028401532161 1.0 0.8374606491676082 13 O75844,Q14108 2 |
| Extracellular vesiclemediated signaling in recipient cells 0.3970788043478369 0.476193785363862 0.6339363265561127 1.0 0.8542505207628334 4 Q9NWH9,P42345,P25054 3 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.4139996003174196 0.4485761913759142 0.6537374119879349 1.0 0.8563018737524328 5 Q13546,O14920 2 |
| 16p112 distal deletion syndrome 0.4250537433982134 0.4349325185743158 0.6636114099437858 1.0 0.8632693882602062 7 P62993,Q9H2V7 2 |
| Copper homeostasis 0.4034576381968531 0.4299625394931546 0.6672228912020133 1.0 0.8660927810203239 9 P35670,P25054,O75880,Q04656 4 |
| Metapathway biotransformation phase i and ii 0.3196170879497229 0.4170988151074737 0.6766061315758463 1.0 0.87124485311151 23 Q8NCH0,Q16850,Q86UY6,Q6UW02,P21964 5 |
| Fluoropyrimidine activity 0.3869941735166267 0.4093286670641824 0.6822984805090262 1.0 0.8724710357147335 10 Q06203,P00374,P31350 3 |
| Aryl hydrocarbon receptor pathway wp2586 0.4061224489795923 0.3950790994384324 0.692784513055271 1.0 0.8762731988845673 8 O00170,P28482,P48506,P07900,P24941,Q16543,P21359 7 |
| Novel intracellular components of rigilike receptor rlr pathway 0.4042360562969614 0.3868591726932209 0.6988604677420756 1.0 0.8762731988845673 8 Q13546,Q92841,O00571,O14920 4 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.3738149767312856 0.3831973913282293 0.7015734120979022 1.0 0.8762731988845673 11 P35610,P04035,P37268 3 |
| Wntbetacatenin signaling pathway in leukemia 0.3972137274889632 0.3771109097176431 0.7060911839549004 1.0 0.8762731988845673 5 P49841,P48729,P14923,P25054 4 |
| Tgfbeta receptor signaling 0.3972137274889619 0.3771109097176371 0.7060911839549049 1.0 0.8762731988845673 5 P62942,P27361,P40763,P42224 4 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.3972137274889619 0.3771109097176371 0.7060911839549049 1.0 0.8762731988845673 5 P62942,P27361,P40763,P42224 4 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.3905524072955542 0.3710185740301762 0.7106236974370188 1.0 0.8762731988845673 9 P31943 1 |
| Nucleotidebinding oligomerization domain nod pathway 0.3949135789366415 0.3469268744464679 0.7286462561907836 1.0 0.8908870295527757 8 Q9P0J0 1 |
| Mthfr deficiency 0.4036540065727617 0.3454149083831336 0.7297824708387302 1.0 0.8908870295527757 7 Q7L592,Q96KQ7 2 |
| Ccl18 signaling pathway 0.3941497880359317 0.3437082222267054 0.731065727064943 1.0 0.8908870295527757 8 P00403 1 |
| White fat cell differentiation 0.32665534804754 0.3420988182193466 0.7322765267871401 1.0 0.8908870295527757 3 Q04726,P16220 2 |
| Il7 signaling pathway 0.4058463630183648 0.3213567473599765 0.7479400567708363 1.0 0.902192217389872 6 P27361,P28482,P40763,P49841,P42224 5 |
| Oxidative phosphorylation 0.2926220633158743 0.3113303492662277 0.7555494975315851 1.0 0.9063577804720212 30 O96000,O75964,P03886,Q9Y6M9,Q86Y39,P06576,P00846 7 |
| Translation inhibitors in chronically activated pdgfra cells 0.3133612988453983 0.3071124895666222 0.7587577514967094 1.0 0.9083932443217576 17 P31751 1 |
| Disruption of postsynaptic signaling by cnv 0.3738099223506343 0.2981424303151226 0.7655944585696575 1.0 0.911133207129434 9 Q14168,Q13555,Q06787,P61981 4 |
| Mirna biogenesis 0.3519021739130418 0.2815585710486591 0.7782820109260871 1.0 0.9169144193997136 4 Q8WYQ5,Q9HAV4,Q9UPY3 3 |
| Erbb signaling pathway 0.3086418118060697 0.2799702208809433 0.7795003518985428 1.0 0.9169144193997136 17 Q13555,P31751,P19174 3 |
| Ras signaling 0.2930735515770983 0.2778444711377627 0.7811317516350307 1.0 0.9169144193997136 27 Q9UQ13,P31751,P19174,P62993,P11233,Q9UJF2,O14920 7 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.3496016331396662 0.2695918539947075 0.7874742679541735 1.0 0.9197591114469676 11 P31751,P24941 2 |
| Small cell lung cancer 0.3491121156469702 0.2674094279913553 0.7891539411861486 1.0 0.9197591114469676 11 P31751,P11802,O14920,P24941 4 |
| 22q112 copy number variation syndrome 0.2841672659309495 0.264743468025944 0.7912070892147791 1.0 0.9197591114469676 32 P00367,O94788,Q92973,Q9NQC3,Q96DF8,P21964 6 |
| Mrna processing 0.249391188843097 0.2516111164724298 0.801341665312876 1.0 0.9266390492927572 94 P38159,P61978,P55795,Q8IWZ8,O75494,P07910,Q99729,O43390,Q15233,P09651,Q08170,P67809,P49755,Q07955,P23246,Q13242,Q16629,Q99873,Q5KU26,P35637,P22626,P62995,P26368,Q14103,P31943 25 |
| Preimplantation embryo 0.3731342680874391 0.2286401104212194 0.8191486466122353 1.0 0.9297264905336464 7 Q99729 1 |
| Wnt signaling pathway and pluripotency 0.3232685799130997 0.2172509877546531 0.8280127509443456 1.0 0.9336504002205472 13 O14641,P30154,P30153,P25054,O60716 5 |
| Tcell activation sarscov2 0.3145498892464781 0.2134882715194828 0.8309461362358743 1.0 0.9337684220131977 14 P19174,P62993 2 |
| Glycerolipids and glycerophospholipids 0.2964346349745358 0.2117159802946202 0.8323286202304969 1.0 0.9337684220131977 3 Q9UG56,P48651 2 |
| Ranklrank signaling pathway 0.3130516548171346 0.2064099578566257 0.8364706930663857 1.0 0.9344217221801074 14 P31751,P19174 2 |
| Complement and coagulation cascades 0.294057724957561 0.2023662156301571 0.8396304379976836 1.0 0.9347486539308713 3 P49257,P10909 2 |
| Melanoma 0.3036353719135114 0.2012156010854151 0.8405299930677088 1.0 0.9347486539308713 15 P31751,P11802,P62993,P0DP25 4 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.3262264215411204 0.1980772258007762 0.8429846429792549 1.0 0.9347486539308713 12 P19174,O14920,P62993 3 |
| Endometrial cancer 0.3165427384596541 0.1871557312470272 0.8515385328295868 1.0 0.9361236026566324 13 P31751,P62993 2 |
| Met in type 1 papillary renal cell carcinoma 0.2873818151280592 0.1867753935008927 0.8518367405357812 1.0 0.9361236026566324 21 P31751,P19174,Q92733 3 |
| Proximal tubule transport 0.3402667624332157 0.1671016367885282 0.8672900781525696 1.0 0.9361236026566324 9 P08183,P05023,P36543,P05026 4 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.3396040078152799 0.16474286924177 0.8691463731820313 1.0 0.9361236026566324 9 Q13555 1 |
| Mitochondrial gene expression 0.3334276748638553 0.1438550432364413 0.8856149366392658 1.0 0.9521548782114468 5 O00411,Q9P2K5 2 |
| Pi3kakt signaling pathway 0.2642655235518318 0.1267118055255801 0.8991685017010025 1.0 0.9602117317369984 35 P31751,P13807,P62993,P11802,P30154,P30153,O14920,P24941,P23588,P16220 10 |
| Embryonic stem cell pluripotency pathways 0.3001586087377528 0.1191176942125211 0.9051821125958708 1.0 0.964287955804335 13 O14641,P31751,P62993 3 |
| Retinoblastoma gene in cancer 0.254878040102827 0.1173234315705076 0.906603757547058 1.0 0.964287955804335 45 Q16204,Q14566,P00374,Q9Y619,Q13547,P09455 6 |
| Breast cancer pathway 0.271211546015254 0.1071637008727743 0.914659112060813 1.0 0.9695063956764524 22 P31751,P62993,P11802,O14641 4 |
| P53 transcriptional gene network 0.3191694323489622 0.0969319413449637 0.9227804427106538 1.0 0.9763926867413784 9 P04066 1 |
| Heme biosynthesis 0.296563260620305 0.0934183612404647 0.9255712041428614 1.0 0.977624417732618 4 P22830 1 |
| Il6 signaling pathway 0.3060869365114577 0.0812903457922349 0.9352110515230287 1.0 0.9860734069567372 10 Q13547 1 |
| Type 2 papillary renal cell carcinoma 0.3139164715670022 0.0635616425967058 0.9493192747260136 1.0 0.9974490980949896 8 P23246,Q92733 2 |
| Male infertility 0.2642558451820492 0.0607467265672349 0.951560917949 1.0 0.998059531740574 18 P08183 1 |
| Pdgf pathway 0.2768732062656421 0.0564172066132803 0.9550094498906784 1.0 0.9999314971851876 14 P00403,P19174 2 |
| Pathways affected in adenoid cystic carcinoma 0.2815494143329675 0.0517870913882356 0.9586983413296206 1.0 1.0 13 Q9UBU8,Q96T88 2 |
| Spinal cord injury 0.2532889394343746 0.0170207378011536 0.9864200717948346 1.0 1.0 19 P24941,P11802,P14174,Q9NQC3,P08670,Q08722 6 |
| Tcell receptor tcr signaling pathway 0.2490257271950348 0.0015743864637825 0.9987438218667576 1.0 1.0 18 P62993,P19174,P08670 3 |
|
|
